drugset / Trial / NCT02867878

Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome

NCT02867878

Phase 2 Terminated 5 enrolled University Hospital of Ferrara
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators will randomize patients admitted to hospital with Takotsubo diagnosis to systematic high-dose adenosine infusion for 3 minutes (in addition to standard of care) vs. standard of care. The primary aim of the study is to demonstrate that adenosine infusion is associated with a larger and more rapid recovery of left ventricle function.

Timeline

Start
2016-08
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule 140 ug/kg Intravenous